Genscript Biotech Corp
Genscript Biotech's GHG Emissions Data Preview
In 2024, Genscript Biotech completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).
However, Genscript Biotech has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Scope 1 | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Scope 2 | ||||
Market-Based | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data. | 0000000 |
Location-Based | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data. a | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 3 | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 1 Revenue Intensity (tCO2e/$M) | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data. | 0000000 |
Verified Sources Behind Genscript Biotech’s Greenhouse Gas (GHG) Emissions Data
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Genscript Biotech’s data sources below and access millions more through our Disclosure Search.
Insights into Genscript Biotech's Operational Emissions
In 2024, the total operational greenhouse gas (GHG) emissions of Genscript Biotech amounted to 151,664.17 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a
Compared to 2023, the total operational greenhouse gas (GHG) emissions of Genscript Biotech increased by 14.39%, suggesting that the company faced challenges in reducing its emissions from its core operations. a
Genscript Biotech's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are Genscript Biotech's Scope 1 emissions?
In 2024, the total Scope 1 emissions of Genscript Biotech were 39,376.8 metric tons of CO₂ equivalent (tCO₂e). a
Compared to the previous year (2023), Genscript Biotech's Scope 1 emissions decreased by 19.35%, highlighting the company's efforts to lower direct emissions from assets it owns or controls. a
What are Genscript Biotech's Scope 2 emissions?
In 2024, Genscript Biotech reported Scope 2 greenhouse gas (GHG) emissions of 114,034.82 tCO₂e using the market-based method and 112,287.37 tCO₂e using the location-based method. a
Has Genscript Biotech reduced its Scope 2 emissions over time?
Compared to the previous year (2023), Genscript Biotech's Scope 2 emissions (Location-Based) rose by 34.06% in 2024, suggesting that the company faced challenges in reducing emissions from purchased electricity and energy a
What methodology does Genscript Biotech use for Scope 2 reporting?
In 2024, Genscript Biotech reported its Scope 2 emissions using the market-based method and using the location-based method. a
Genscript Biotech's Scope 2 Emissions Over Time
- Total Scope 2 Location-Based
- Total Scope 2 Market-Based
Insights into Genscript Biotech's Value Chain Emissions
In 2024, Genscript Biotech reported 387,028 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain. a
The 2024 disclosure of Genscript Biotech includes a breakdown across 0 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in 2023, demonstrating consistent Scope 3 emissions reporting coverage year over year. a
Genscript Biotech's Scope 3 Emissions Over Time
- Total Scope 3
- Year-over-Year Change
What are Genscript Biotech's Scope 3 emissions?
In 2024, Genscript Biotech reported total Scope 3 emissions of 387,028 metric tons of CO₂ equivalent (tCO₂e). a
Compared to the previous year (2023), Genscript Biotech's Scope 3 emissions increased by 23%, suggesting that the company faced challenges in reducing emissions across its value chain. a
Insights into Genscript Biotech’s GHG Emissions Intensity Compared to Industry Peers
In 2024, Genscript Biotech reported Scope 1 greenhouse gas (GHG) emissions of 39,376.8 tCO₂e and total revenues of USD 4,637 millions. This translates into an emissions intensity of 8.49 tCO₂e per millions USD. a
Genscript Biotech's Scope 1 Emissions Intensity Compared to Peers
How does Genscript Biotech's GHG emissions intensity compare to its peers?
In 2024, Genscript Biotech reported a Scope 1 emissions intensity of 8.49 tCO₂e per millions USD. Compared to the peer group median of 9.75 , this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors. a
Where does Genscript Biotech rank on GHG emissions intensity within its industry?
In 2024, Genscript Biotech ranked 12 out of 23 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a
Genscript Biotech is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency. a
Insights into Genscript Biotech's Total Carbon Footprint
In 2024, Genscript Biotech reported a total carbon footprint of 538,692.17 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 20.45% increase compared to 2023, suggesting a rise in emissions across its operations or value chain. a
The largest contributor to Genscript Biotech's total carbon footprint was Scope 3 emissions, accounting for 71.85% of the company's total carbon footprint, followed by Scope 2 emissions at 20.84%. a